ロード中...

Polycythemia vera treatment algorithm 2018

Recently reported mature survival data have confirmed the favorable prognosis in polycythemia vera (PV), with an estimated median survival of 24 years, in patients younger than age 60 years old. Currently available drugs for PV have not been shown to prolong survival or alter the natural history of...

詳細記述

保存先:
書誌詳細
出版年:Blood Cancer J
主要な著者: Tefferi, Ayalew, Vannucchi, Alessandro M., Barbui, Tiziano
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group UK 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5802495/
https://ncbi.nlm.nih.gov/pubmed/29321547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-017-0042-7
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!